Study on the regimen of neohuoxin (recombinant human BNP) sequential sacubatril/valsartan (LCZ696) in the treatment of acute heart failure
Latest Information Update: 18 May 2021
At a glance
- Drugs Sacubitril/valsartan (Primary) ; ACE inhibitors; Beta adrenergic receptor antagonists; Steroid receptor antagonists
- Indications Acute heart failure
- Focus Therapeutic Use
Most Recent Events
- 23 Apr 2021 Status changed from not yet recruiting to completed, as per results published in the Medicine.
- 23 Apr 2021 Results published in the Medicine
- 16 Apr 2018 New trial record